Available IPD datapackage for study 'A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus'

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as dulaglutide when added to sodium-glucose co-transporter 2 (SGLT2) inhibitors in participants with type 2 diabetes mellitus.

本研究的主要目的为评估针对2型糖尿病患者，在其接受钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂治疗的基础上加用研究药物度拉糖肽（dulaglutide）时的疗效与安全性。